Abstract
Glucagon-like peptide-1 (GLP-1) analogues have emerged as promising therapeutic agents for the treatment of type 2 diabetes. Recent studies have suggested a potential role of GLP-1 in reproductive functions, offering new avenues for fertility treatment. This paper aims to review the current understanding of GLP-1 analogues to human reproduction, focusing on their potential application in fertility treatment, and discussing the molecular mechanisms and signalling pathways involved. Further, we highlight the challenges and future directions in the application of GLP-1 analogues for fertility treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
